News

Company updates, partnerships, conferences, and laboratory milestones

Two Peptone team members reviewing a 96-well assay plate and printed result in a bright laboratory. Illustrative generated image based on Peptone team portraits.
Latest
AI-generated editorial image of a cloud-native conference stage with Kubernetes clusters and scientific protein-computing visuals.

Carlo Fisicaro and Fabio Airoldi present Peptone's ultra-scalable architecture at KubeCon 2025

Peptone presented its Kubernetes and AWS architecture for protein structure prediction to more than 8,000 attendees at KubeCon + CloudNativeCon Europe 2025.

Read story

Recent updates

AI-generated editorial image of biomedical advisors reviewing molecular research around a conference table in London.

Peptone convenes Advisory Board meeting with pharmaceutical and biomedical research experts in London

Peptone brought its scientific advisors together in London to review findings, guide its small molecule programs, and assess new intrinsically disordered protein targets.

Archive

2024

  1. Peptone presents ProteinMPNN-ddG at NeurIPS 2024

    Peptone's AI team presented ProteinMPNN-ddG, a faster method for estimating how point mutations change the stability of monomeric and multimeric proteins.

2023

  1. Peptone recognized in Nature Biotechnology's academic spinouts survey

    Nature Biotechnology selected Peptone for its annual academic spinouts survey, recognizing the company's work on intrinsically disordered proteins.

  2. Peptone presents Sentence Transformers research at NeurIPS 2023

    Peptone's AI team presented a Sentence Transformers approach for fine-tuning protein language models at the NeurIPS 2023 Biology Track.

  3. Peptone and the Institute of Oncology Research announce collaborative research agreement

    Peptone and the Institute of Oncology Research in Bellinzona began a sponsored research collaboration to identify and advance novel prostate cancer targets.

  4. PwC included Peptone in The Life Sciences Future 50, a report highlighting innovative companies in Britain's life sciences sector.

  5. Peptone to present at Swiss Biotech Day 2023

    Peptone CEO Dr. Kamil Tamiola was scheduled to present the company at Swiss Biotech Day 2023 in Basel.

  6. Peptone to present disordered cytokine engineering research at Prague Protein Spring 2023

    Peptone joined Prague Protein Spring 2023 with a talk on using generative AI to rationally modulate intrinsic disorder in cytokines.

2022

  1. Peptone CEO Kamil Tamiola joins Young Sohn's Next Wave podcast

    Peptone co-founder and CEO Dr. Kamil Tamiola joined Young Sohn to discuss biophysics, high-performance computing, machine learning, and intrinsically disordered proteins.

  2. Nature published a commercial executive summary introducing Peptone's science and business to prospective employees, collaborators, and stakeholders.

  3. Peptone and Studio Gusto win an Awwwards honor for brand design

    Peptone and Studio Gusto received an Awwwards honor for Peptone's website and brand identity.

  4. Peptone and Studio Gusto win an FWA for brand and website design

    Peptone and Studio Gusto received a Favourite Website Award for the design of Peptone's brand identity and website.

  5. Peptone closes $40 million Series A led by F-Prime and Bessemer Venture Partners

    Peptone raised a $40 million Series A to expand its Bellinzona research facility, advance its supercomputing capabilities, and develop therapeutics against intrinsically disordered proteins.

  6. Peptone opens advanced experimental biophysics laboratory in Bellinzona

    Peptone opened a Bellinzona laboratory dedicated to advanced experimental studies of intrinsically disordered proteins.

  7. Peptone selected to use NVIDIA's Cambridge-1 supercomputer

    Peptone gained access to NVIDIA's Cambridge-1 supercomputer to accelerate AI-driven protein engineering and research into intrinsically disordered proteins.

  8. Dr. Patrick Kunz joins Peptone as Head of Experimental Biophysics

    Dr. Patrick Kunz joined Peptone as Head of Experimental Biophysics, bringing experience in protein analytics and biologics formulation development.

2021

  1. Dr. George Golumbeski joins Peptone as Board and Executive Advisor

    Biopharmaceutical dealmaker Dr. George Golumbeski joined Peptone as a Board and Executive Advisor.

  2. Peptone partners with NVIDIA and Verne Global

    Peptone installed an NVIDIA DGX A100 at Verne Global's renewable-energy data center in Iceland and expanded its collaboration with NVIDIA.

2020

  1. Peptone closes $2.5 million seed round led by Hoxton Ventures

    Peptone raised $2.5 million from Hoxton Ventures, dRX Capital, and Founders Factory to develop its protein-engineering system, grow its team, and build computing capacity in Iceland.